Philip Morris International Stock Earnings Reports

PMI reported a strong Q1 driven by international smoke-free products (IQOS, ZYN, VEEV) and robust pricing. Net revenues exceeded $10 billion, up 9% reported and 2.7% organic; adjusted gross profit grew 10% to $6.9 billion; adjusted operating income rose 10% to $4.2 billion; adjusted diluted EPS increased 16% to $1.96 (including a $0.18 FX tailwind). International smoke-free volumes and profitability were standout metrics (HTU and e‑vapor growth; IQOS IMS +10.9%; smoke-free gross margin expansion to ~70%). Combustible business showed resilient pricing-led revenue and margin expansion despite high-end volume declines. U.S. ZYN offtake grew ~10% but shipments were down due to downstream inventory normalization; management expects U.S. performance to improve through 2026 with planned product innovations and manufacturing ramp-up. Company reconfirmed its 2026 currency-neutral guidance: broadly stable shipments, organic net revenue +5–7%, organic operating income +7–9%, and organic adjusted EPS +7.5–9.5% (updated dollar EPS $8.36–$8.51 reflecting a ~$0.25 FX tailwind). Management emphasized ongoing investment in smoke-free growth, margin expansion, cost efficiencies (~$150m realized in Q1), and continued shareholder returns via progressive dividend policy. Risks noted include macro uncertainty, excise/tax changes (e.g., Japan, Mexico, potential U.S. state excises), regulatory timing in the U.S. (FDA reviews), and regional disruptions (Middle East, Ukraine).